
Monash University
A true mentor who cares about success.
Inspires students to reach new heights.
Creates a safe and inclusive space.
Makes learning interactive and fun.
Encourages deep understanding and curiosity.
Professor Andrew Sinclair is a distinguished academic and researcher at Monash University, Australia, with a globally recognized expertise in genomics and pediatric health. His work has significantly advanced the understanding of genetic mechanisms underlying disorders of sex development (DSD) and other congenital conditions. With a career spanning decades, he holds prominent leadership roles and has contributed extensively to both research and policy in medical genetics.
Professor Sinclair earned his PhD in Molecular Biology from the University of London. His academic training laid a strong foundation in genetics and molecular mechanisms, which he has applied throughout his career to address critical challenges in pediatric and reproductive health.
Professor Sinclair’s research focuses on the genetic basis of human sex determination and disorders of sex development. His work integrates cutting-edge genomic technologies to identify novel genes and pathways involved in these conditions. Key areas of interest include:
Professor Sinclair has held numerous prestigious positions throughout his career, reflecting his expertise and leadership in medical genetics:
Professor Sinclair’s contributions to science and medicine have been widely recognized through numerous accolades:
Professor Sinclair has authored over 200 peer-reviewed publications, including seminal works on sex determination and genomics. Some notable publications include:
Professor Sinclair’s groundbreaking discovery of the SRY gene as a key determinant of male sex development in the early 1990s remains a cornerstone of developmental biology. His research has not only deepened scientific understanding but also improved clinical diagnostics and management for patients with DSD. Additionally, his leadership in genomic research has influenced national and international guidelines for genetic testing and patient care.
Professor Sinclair is actively involved in shaping the field through public engagement and editorial roles: